Theresa D. Ahrens

Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine

Theresa D. Ahrens, Sylvia Timme, Jens Hoeppner et al. · Epigenetics · 2015 · 75 citations · Full text

Medicine, Oncology, Pharmacology +17

Tumor Cell Heterogeneity in Small Cell Lung Cancer (SCLC): Phenotypical and Functional Differences Associated with Epithelial-Mesenchymal Transition (EMT) and DNA Methylation Changes

Alexander Krohn, Theresa D. Ahrens, Arzu Yalcin et al. · PLoS ONE · 2014 · 69 citations · Full text

Medicine, Cell Biology, Oncology +17

Form follows function: Morphological and immunohistological insights into epithelial–mesenchymal transition characteristics of tumor buds

Kathrin Enderle-Ammour, M Bader, Theresa D. Ahrens et al. · Tumor Biology · 2017 · 68 citations · Full text

Veterinary Medicine, Oncology, Pathology +17

Capture and Detection of Circulating Glioma Cells Using the Recombinant VAR2CSA Malaria Protein

Sara R. Bang-Christensen, Rasmus S. Pedersen, Marina Ayres Pereira et al. · Cells · 2019 · 66 citations · Full text

Medicine, Cancer Biology, Oncology +16

Double deficiency of cathepsins B and L results in massive secretome alterations and suggests a degradative cathepsin-MMP axis

Stefan Tholen, Martin L. Biniossek, Martina Gansz et al. · Cellular and Molecular Life Sciences · 2013 · 39 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +12